EMA — authorised 18 April 2002
- Marketing authorisation holder: Merck Sharp & Dohme Ltd
- Status: approved
🇪🇺 Invanz in European Union
EMA authorised Invanz on 18 April 2002
Marketing authorisation
Invanz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Invanz approved in European Union?
Yes. EMA authorised it on 18 April 2002.
Who is the marketing authorisation holder for Invanz in European Union?
Merck Sharp & Dohme Ltd holds the EU marketing authorisation.